NFKB1 and Miyoshi myopathy: We demonstrated that NNU219 inhibited tumor cell proliferation, induced the G2/M-phase arrest and apoptosis, downregulated NF-κB expression, and finally triggered an ER stress response in human MM cell lines and patient-derived cells at nanomolar concentrations.